Challenges in Delivering Care for Hematolymphoid Disorders during the COVID-19 Pandemic : Insights from a Tertiary Center in Kerala, India
Abstract
Background: The COVID-19 pandemic led to significant reallocation of healthcare resources toward emergency care, often at the cost of patients with non-COVID conditions. Individuals with haemato-lymphoid diseases, many of whom are immunocompromised and require continuous, intensive therapy, were particularly at risk. This study aimed to evaluate the impact of the pandemic on the care of patients with hematological diseases in a resource-limited setting in India.
Methods: A cross-sectional study was conducted at the Regional Advanced Centre for Transplantation, Haemato-Lymphoid Oncology and Marrow Diseases (RACTHAM), Believers Church Medical College Hospital, Kerala. All patients who received care between April 1st 2020 and December 31st 2020 were included. Data were gathered through structured interviews during outpatient visits or via telephone. Information on diagnosis, care access, treatment disruptions, follow-up delays, and COVID-19-related outcomes was collected and analysed descriptively.
Results: Among the 505 patients interviewed (mean age 47.95 ± 20.5 years; 50.6% male), 74.3% had benign hematological disorders and 25.7% had malignant conditions. Care disruptions due to the pandemic were reported by 13.5%, while 31.3% reported shifting their primary treatment center. Follow-up visits were affected in 4.9% and investigations were deferred in 2.4%. Treatment modification or discontinuation occurred in only 0.6%. Transfusion services remained uninterrupted. Telemedicine was accessed by just 2.9% of patients. Eight patients (1.5%) tested positive for COVID-19, and the overall mortality was 3.9%, largely unrelated to COVID.
Conclusion: While core hematology services such as chemotherapy and transfusion were largely maintained, logistical and access-related disruptions were common during the COVID-19 pandemic. The findings underscore the importance of strengthening decentralized care models, formalizing transition systems, and expanding telemedicine in hematology to ensure continuity of care during public health crises.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
When publishing with Kerala Medicial Journal (KMJ), authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Work includes the material submitted for publication and any other related material submitted to KMJ. In the event that KMJ does not publish said work, the author(s) will be so notified and all rights assigned hereunder will revert to the author(s).
The assignment of rights to KMJ includes but is not expressly limited to rights to edit, publish, reproduce, distribute copies, include in indexes or search databases in print, electronic, or other media, whether or not in use at the time of execution of this agreement.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
The author(s) hereby represents and warrants that they are sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, that the work is original, and does not infringe upon any copyright, propriety, or personal right of any third party, and that no part of it nor any work based on substantially similar data has been submitted to another publication.
